Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...

A local college student is in the fight of his life, battling cancer. Lackawanna County residents are rallying around him as ...

Mid Valley High School graduate Eddie Kaufman has always been a team player, whether on the baseball field or the golf course ...

Axi-cel, tisa-cel, and brexu-cel were found comparable to other cellular therapy experiences for patients with B-cell ...

Helix BioPharma is a clinical-stage biopharmaceutical company aiming to turn scientific breakthroughs into real-world ...

An Omaha girl with a rare, high-risk form of leukemia is smiling through life against all odds, so Make-A-Wish made the ...

In March 2025, Juventas Cell Therapy Ltd. conducted a phase Ib/II trial to evaluate the safety and efficacy of CNCT19 ...

Researchers sought to determine whether patients with T-ALL would be responsive to salvage therapy with homoharringtonine, cytarabine, and aclarubicin.

On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell therapy, for the treatment of pediatric and adult patients with ...

For many decades, the foundations of cancer treatment have been surgery, chemotherapy, and radiation therapy. But, in recent years, a newer therapy in the form of immunotherapy has emerged, ...

One former Elmira Pioneer needs the support of the Twin Tiers. Last summer, standout outfielder Eddie Kaufman gave Elmira ...

Everything we do, we do for our B+ Heroes,” is not only a phrase that fills the halls of Jake Nevin on the day of NOVAdance, but serves as a constant reminder of NOVAdance’s purpose throughout the ...